相关实验视频
Updated: Jan 16, 2026

08:10
Robotic Lateral Pancreaticojejunostomy for Chronic Pancreatitis
Published on: December 14, 2019
11.6K
慢性质子抑制剂使用中的胰腺功能:跨截面研究的发现
Leo Francis Chalissery1, Madhavi Eerike2, Lisha Francis Chalissery3
1Senior Resident, Department of Pharmacology, All India Institute of Medical Sciences, Bibinagar, Hyderabad, Telangana, India, PIN-508126.
Maedica
|January 15, 2026
概括
长期使用质子抑制剂 (PPI) 与胰腺功能障碍没有明确的联系. 然而,HbA1c升高的高患病率表明需要进一步调查的潜在关联.
科学领域:
- 胃肠病学 胃肠病学
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 质子抑制剂 (PPI) 经常用于与酸有关的胃肠道疾病.
- 新兴研究表明,长时间使用PPI和胰腺功能障碍之间可能存在联系,但证据是相互矛盾的.
- 这项研究研究了长期接受PPI治疗的个体的胰腺功能标志物.
研究的目的:
- 在接受慢性质子抑制剂治疗的患者中评估胰腺功能.
- 探索PPI使用与胰腺健康标志物之间的潜在关联.
- 澄清长期PPI治疗与胰腺功能障碍之间的关系.
主要方法:
- 一项横截面研究包括97名成人门诊患者使用PPI至少8周 (≥3剂/周).
- 排除标准包括糖尿病或同时使用影响葡萄糖的药物.
- 血液测试测量了C-,氨酶,糖化血红蛋白 (HbA1c) 和随机血糖 (RBS);统计分析确定了相关性.
主要成果:
- 研究人口的平均年龄为51.2岁,女性为62.9%;潘托普拉是最常见的PPI (76.3%).
- 在10.3%的参与者中发现异常的C-水平,表明胰腺功能障碍.
- 增加的HbA1c水平很普遍 (48.5%),但胰腺功能标志物与年龄,性别,PPI类型或持续时间之间没有发现显著的关联.
结论:
- 这项研究没有确定慢性PPI使用与胰腺功能障碍之间的确切联系.
- 长期使用PPI的人群中HbA1c升高的高发病率要求进一步调查潜在的关联.
- 需要进一步的研究来阐明PPI和胰腺健康之间的复杂关系.
相关概念视频
Chronic Pancreatitis I: Introduction
666
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
666
Chronic Pancreatitis II: Collaborative Care
311
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
311
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
845
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
845
Peptic Ulcer Disease IV: Management
430
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
430
Peptic Ulcer Disease I: Introduction
742
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
742
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
1.1K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.1K

